Recombinant CA9 (Girentuximab Biosimilar) antibody

Catalog No. ABIN7597723

The Chimeric Chimeric anti-CA9 (Girentuximab Biosimilar) antibody has been validated for . It is suitable to detect CA9 (Girentuximab Biosimilar) in samples from Human.

Quick Overview for Recombinant CA9 (Girentuximab Biosimilar) antibody (ABIN7597723)

Target: CA9 (Girentuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: This CA9 (Girentuximab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CA9 (Girentuximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Girentuximab Biosimilar Antibody

Specificity: Membrane antigen MN, P54/58N, Carbonic anhydrase 9, Renal cell carcinoma-associated antigen G250, CA-IX, CAIX, pMW1, Carbonic anhydrase IX, RCC-associated antigen G250, Carbonate dehydratase IX, CA9, MN, G250

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CA9 (Girentuximab Biosimilar)

Target: CA9 (Girentuximab Biosimilar)

Alternative Name: Girentuximab Biosimilar

Target Type: Biosimilar

Background: Membrane antigen MN, P54/58N, Carbonic anhydrase 9, Renal cell carcinoma-associated antigen G250, CA-IX, CAIX, pMW1, Carbonic anhydrase IX, RCC-associated antigen G250, Carbonate dehydratase IX, CA9, MN, G250

UniProt: Q16790

CAS-No: 916138-87-9